Back

The additive prognostic value of C-reactive protein for all-cause and cardiovascular mortality across the PREVENT-defined cardiovascular risk continuum: a nationally representative cohort study

31 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Atherosclerosis as an inflammatory process (2) Cardiovascular Risk Assessment ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Vikash Jaiswal

Endeavor Health, Glenview (United States of America)

6 More presentations in this session

Presentation thumbnail
SMART2 recurrent CVD event risk for stratification of cumulative healthcare costs
Mr J. Ebbers (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Epigenetic vs chronologic age for cardiovascular risk assessment
Doctor R. Ibrahim (Phoenix, US)
Abstract Slides Video
Presentation thumbnail
Long-term cardiovascular risk following COVID-19 hospitalisation in a large US health system: temporal and prediction modelling
Doctor G. Fontana (Thousand Oaks, US)
Abstract Slides Video
Presentation thumbnail
Integrated clinical and polygenic coronary artery disease risk score predicts 10-year progression of coronary artery plaque
Mr B. Weijs (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Differential associations of cardiorenal-inflammatory markers with incident cardiovascular disease and cancer in the general population
Doctor Y. YANG (Rotterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Atherosclerosis as an inflammatory process (2)

The Event

Event poster

ESC Congress 2026

31 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
High-sensitivity C-reactive protein as a predictor of cardiovascular events in young patients following myocardial infarction
1 September 2025
thumbnail
Congress Presentation
Cardiovascular-kidney-metabolic syndrome and association with mortality in the UK Biobank prospective cohort study
1 September 2025
thumbnail
Congress Presentation
The added value of ECG on the PREVENT CVD risk score for the prediction of subclinical cardiac disease - insights from Project Baseline Health Study
29 August 2025
thumbnail
Congress Presentation
Apolipoprotein B/apolipoprotein A-I ratio is comparable with C-reactive protein in predicting cancer mortality: results from two multi-ethnic US populations.
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources